anifrolumab - Robuta Search

https://www.lupus.org/news/new-study-finds-anifrolumab-in-addition-to-standard-of-care-treatment-is-effective-at-reducing

New Study Finds Anifrolumab In Addition to Standard of Care Treatment is Effective at Reducing...

new study finds anifrolumab addition standard

https://www.pharmaceutical-technology.com/data-insights/anifrolumab-astrazeneca-chronic-cutaneous-lupus-erythematosus-ccle-discoid-lupus-erythematosus-dle-likelihood-of-approval/

Anifrolumab by AstraZeneca for Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus...

Anifrolumab is under clinical development by AstraZeneca and currently in Phase III for Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus...

cutaneous lupus erythematosus anifrolumab astrazeneca chronic discoid